Propiedad y actividad de insiders de Trevi Therapeutics, Inc. (TRVI): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $15.89 |
| Capitalización | $2.3B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.3M | $22.0M | $17.2M | $57.3M | $45.0M | $36.8M | $12.6M | $32.4M | $34.1M | $18.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $107.9M | $50.6M | $73.5M | $169.3M |
| Cuentas por Cobrar | $19000 | 0 | $184000 | $558000 | 0 | $241000 | 0 | 0 | $532000 | $986000 |
| Inventario | 0 | $63000 | $1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.4M | $22.2M | $18.8M | $59.6M | $46.3M | $38.0M | $122.6M | $87.5M | $109.4M | $191.7M |
| Inmovilizado Material | $5000 | $14000 | $149000 | $430000 | $330000 | $184000 | $194000 | $1.6M | $1.2M | $855000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $8.4M | $22.2M | $20.5M | $60.0M | $47.1M | $38.5M | $123.0M | $89.4M | $110.9M | $193.4M |
| Cuentas por Pagar | $445000 | $537000 | $603000 | $1.6M | $2.0M | $2.8M | $2.9M | $1.8M | $3.4M | $3.9M |
| Deuda a Corto | $17.0M | $5.3M | 0 | 0 | 0 | $5.8M | $7.0M | 0 | 0 | 0 |
| Pasivos Corrientes | $20.4M | $7.1M | $2.7M | $5.2M | $5.6M | $12.7M | $13.4M | $5.8M | $10.5M | $9.7M |
| Deuda a Largo | $5.1M | 0 | $1.1M | 0 | $14.0M | $8.7M | $2.2M | 0 | 0 | 0 |
| Pasivos Totales | $25.8M | $7.5M | $3.2M | $5.5M | $19.8M | $21.4M | $15.6M | $6.9M | $11.3M | $10.2M |
| Reservas | -$72.2M | -$84.4M | -$109.5M | -$114.2M | -$147.0M | -$180.9M | -$210.1M | -$239.1M | -$287.0M | -$329.8M |
| Patrimonio Neto | -$17.4M | $14.8M | $17.3M | $54.5M | $27.3M | $17.1M | $107.5M | $82.5M | $99.6M | $183.2M |
| Deuda Total | $22.1M | $5.3M | $1.1M | $356000 | $14.2M | $14.6M | $9.2M | $1.3M | $1.0M | $753000 |
| Deuda Neta | $13.8M | -$16.7M | -$16.1M | -$57.0M | -$30.8M | -$22.2M | -$111.3M | -$81.6M | -$106.6M | -$187.5M |
| Capital Circulante | -$12.0M | $15.0M | $16.1M | $54.4M | $40.7M | $25.2M | $109.2M | $81.7M | $98.9M | $181.9M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 37.28 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 104.82 |
Rentabilidad
| Rentabilidad sobre capital | -23.59% |
| Rentabilidad sobre capital invertido | -18.46% |
| Rentabilidad sobre activos | -15.46% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ARDX · NVAX · ORIC · PGEN · TERN · TRML · UPB
Explorar sector: Healthcare · Biotechnology
Más secciones de TRVI: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones